XML 35 R22.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 14 - Stock Incentive and Employee Benefit Plans
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
14.
Stock Incentive and Employee Benefit Plans
 
a.
Stock Incentive Plans
 
The Company has share-based awards outstanding under
three
different plans, pursuant to which we have granted stock options, stock appreciation rights, restricted and unrestricted stock, and performance share awards to key officers, employees, and directors. The exercise price of our share-based awards
may
not be less than the market value of our common stock on the date of grant. Stock options and stock appreciation rights vest based on either time (generally over a
one
to
four
year period) or market performance (based on stock price appreciation) and generally expire between
five
and
ten
years after the date of grant. The fair value for stock options and stock appreciation rights is established at the date of grant using the Black-Scholes model for awards that vest based on time and a lattice model for awards that vest based on market performance. Restricted stock typically vests over a
three
year period and are valued at the closing price on the date of grant. 
 
During the years ended
December
31,
2015
and
2014,
we granted
2.2
million and
1.3
million capped stock appreciation rights, respectively, to our officers and key employees. There were no grants of capped stock appreciation rights during
2016.
The
2015
and
2014
capped stock appreciation rights have a grant price equal to the Company’s common stock closing price on the issuance date, with the value per share of the award capped at
$20.00
above the grant price.
 
The following is a summary of stock option and stock appreciation rights activity relating to our
three
plans on a combined basis for the years ended
December
31,
2016,
2015
and
2014:
 
 
 
2016
 
 
2015
 
 
2014
 
 
 
Number of
Shares
 
 
Weighted
Average
Exercise
Price
 
 
Number of
Shares
 
 
Weighted
Average
Exercise
Price
 
 
Number of
Shares
 
 
Weighted
Average
Exercise
Price
 
Outstanding, beginning of year
   
4,900,617
    $
33.83
     
4,418,308
    $
29.19
     
3,956,373
    $
27.70
 
Granted
   
     
     
2,167,150
     
34.32
     
1,303,054
     
39.50
 
Exercised
   
(408,839
)    
18.61
     
(1,287,216
)    
14.17
     
(524,185
)    
18.20
 
Canceled
   
(484,611
)    
41.34
     
(397,625
)    
48.61
     
(316,934
)    
71.20
 
                                                 
Outstanding, end of year
   
4,007,167
    $
34.47
     
4,900,617
    $
33.83
     
4,418,308
    $
29.19
 
                                                 
Exercisable at end of year
   
2,789,384
    $
33.32
     
2,554,114
    $
28.90
     
1,952,477
    $
19.90
 
                                                 
Available for future grant
   
8,650,219
     
 
     
9,061,407
     
 
     
10,246,013
     
 
 
 
 
At
December
31,
2016,
3,853,751
stock options and stock appreciation rights were vested or expected to vest in the future with a weighted average exercise price of
$34.19
and a weighted average expected life of
1.93
years. During the years ended
December
31,
2016,
2015
and
2014,
the total fair value of stock options and stock appreciation rights vested was
$3.2
million,
$5.0
million and
$2.5
million, respectively. The total intrinsic value of stock options and stock appreciation rights exercised during the years ended
December
31,
2016,
2015
and
2014
was
$5.7
million,
$37.5
million and
$12.6
million, respectively. The intrinsic value of options exercised is the difference between the fair market value of the Company’s common stock on the date of exercise and the exercise price.
 
The following table summarizes information about stock options and stock appreciation rights outstanding and exercisable at
December
31,
2016:
 
Outstanding
 
 
Exercisable
 
Exercise Prices
 
 
Number
 
 
Weighted
Average
Exercise
 
 
Weighted
Average
Remaining
Contractual
 
 
Number
 
 
Weighted
Average
Exercise
 
Low
 
 
High
 
 
 
of Shares
 
 
 
 
Price
 
 
 
 
Life
 
 
 
 
of Shares
 
 
 
 
 
Price
 
$ 17.88     $
21.45
     
1,284,466
    $
19.99
     
0.97
     
1,010,466
    $
19.99
 
$ 28.35     $
41.16
     
1,032,006
    $
38.86
     
3.16
     
539,446
    $
38.86
 
$ 41.95     $
46.45
     
1,690,695
    $
42.79
     
2.04
     
1,239,472
    $
42.79
 
  
As of
December
31,
2016,
the total intrinsic value of stock options and stock appreciation rights outstanding was
$18.1
million, of which
$14.6
 million related to stock options and stock appreciation rights exercisable, and the total intrinsic value of stock options and stock appreciation rights vested and expected to vest in the future was
$18.1
million. The intrinsic value of these stock options and stock appreciation rights outstanding, is the difference between the fair market value of the Company’s common stock on the last trading day of fiscal
2016
and the exercise price.
 
The fair value of each stock appreciation right granted during
December
31,
2015
and
2014
was estimated using the following weighted average assumptions:
 
 
 
 
2015
 
 
2014
 
Dividend yield
   
0.00
%    
0.00
%
Expected volatility
   
40.89
%    
48.44
%
Risk-free interest rate
   
0.93
%    
0.95
%
Expected life (years)
   
3.5
     
3.5
 
 
Based on the above assumptions, the weighted average per share fair value of stock appreciation rights granted during the years ended
December
31,
2015
and
2014,
was
$5.30
and
$4.95,
respectively.
 
Restricted Stock Awards
.
During the years ended
December
31,
2016,
2015
and
2014,
we issued shares of restricted common stock to our officers and key employees which vest in
three
equal installments on each of the
first
three
anniversaries of the issuance date. Compensation expense for these awards is being recognized using the straight-line method
over the vesting period.
 
The following is a summary of unvested restricted stock activity for the years ended
December
31,
2016,
2015
and
2014:
 
 
 
 
2016
 
 
2015
 
 
2014
 
 
 
Number of
Shares
 
 
Weighted Average
Grant Date
Fair Value
 
 
Number of
Shares
 
 
Weighted Average
Grant Date
Fair Value
 
 
Number of
Shares
 
 
Weighted Average
Grant Date
Fair Value
 
Outstanding, beginning of year
   
195,027
    $
41.08
     
154,143
    $
37.55
     
107,706
    $
33.60
 
Granted
   
329,198
     
33.16
     
133,616
     
41.89
     
94,590
     
39.20
 
Vested
   
(84,044
)    
40.96
     
(82,293
)    
35.75
     
(42,310
)    
31.60
 
Canceled
   
(9,363
)    
37.03
     
(10,439
)    
41.26
     
(5,843
)    
33.65
 
Outstanding, end of year
   
430,818
    $
35.14
     
195,027
    $
41.08
     
154,143
    $
37.55
 
 
Performance Share Awards
.
During the years ended
December
31,
2016,
2015
and
2014,
we granted performance share awards to our officers and key employees for which the number of performance share awards ultimately issued will be based on the Company’s actual earnings per share or revenue growth. The
2016
awards
("2016
PSAs") include payouts at
1
-
2
times the target number of shares based on actual revenue growth for the years
2016
-
2018,
subject to a minimum revenue growth threshold. The
2015
awards
("2015
PSAs") include payouts at
1
-
3
times the target number of shares based on actual revenue growth for the years
2016
-
2017,
subject to a minimum revenue growth threshold. The
2014
awards
("2014
PSAs") include payouts at
1
-
4
times the target number of shares based on actual earnings per share for the year ended
December
31,
2016,
subject to a minimum earnings per share threshold. We evaluate the probability of achieving the performance targets established under each of the performance share awards quarterly and estimate the number of shares underlying the performance share awards that are probable of being issued. Compensation expense for these awards is being recognized using the straight-line method over the requisite service period, subject to cumulative catch-up adjustments required as a result of changes in the number shares probable of being issued. Additionally, during the years ended
December
31,
2016,
2015
and
2014,
we granted performance share awards to our officers and key employees for which the number of performance share awards ultimately issued will be based on the Company’s relative total shareholder return ("TSR") performance over a
three
-year period from
2016
-
2018
("2016
TSR PSAs"),
2015
-
2017
("2015
TSR PSAs") and
2014
-
2016
("2014
TSR PSAs"), in comparison to the TSR performance of a comparative peer group selected by our Compensation Committee. The
2016
TSR PSAs include payouts at
1
-
2
times the target number of shares based on actual TSR performance, the
2015
TSR PSAs include payouts at
1
-
3
times the target number of shares based on actual TSR performance, and the
2014
TSR PSAs include payouts at
1
-
4
times the target number of shares based on actual TSR performance, all subject to minimum TSR thresholds. Compensation expense for these awards is being recognized using the straight-line method over the requisite service period.
 
The following is a summary of performance share award activity for the years ended
December
31,
2016,
2015
and
2014:
 
 
 
 
2016
 
 
2015
 
 
2014
 
 
 
Number of
Shares
 
 
Weighted Average
Grant Date
Fair Value
 
 
Number of
Shares
 
 
Weighted Average
Grant Date
Fair Value
 
 
Number of
Shares
 
 
Weighted Average
Grant Date
Fair Value
 
Outstanding, beginning of year
   
198,759
    $
47.63
     
166,031
    $
36.20
     
120,448
    $
29.05
 
Granted
   
319,798
     
30.36
     
348,756
     
30.46
     
45,583
     
55.05
 
Vested
   
(50,429
)    
41.95
     
(316,028
)    
22.68
     
     
 
Canceled
   
     
     
     
     
     
 
Outstanding, end of year
   
468,128
    $
36.45
     
198,759
    $
47.63
     
166,031
    $
36.20
 
 
Other Stock-Based Awards.
During the years ended
December
31,
2016,
2015
and
2014,
we issued
22,710
shares,
13,498
shares and
12,174
shares, respectively, of unrestricted common stock to our independent directors (excluding directors appointed by MatlinPatterson who did not receive any stock awards). 
 
 
Total compensation expense recognized related to stock-based compensation was as follows:
 
 
 
Year Ended December 31,
 
 
 
2016
 
 
2015
 
 
2014
 
 
 
(Dollars in thousands)
 
Stock options and stock appreciation rights
  $
3,309
    $
8,709
    $
3,618
 
Unrestricted stock grants
   
780
     
555
     
480
 
Restricted stock grants
   
4,359
     
3,261
     
1,842
 
Performance share awards
   
9,346
     
3,099
     
2,529
 
Total
  $
17,794
    $
15,624
    $
8,469
 
 
Total unrecognized compensation expense related to stock-based compensation was as follows:
 
 
 
As of December 31,
 
 
 
2016
 
 
2015
 
 
2014
 
 
 
Unrecognized
Expense
 
 
Weighted Average
Period (years)
 
 
Unrecognized
Expense
 
 
Weighted Average
Period (years)
 
 
Unrecognized
Expense
 
 
Weighted Average
Period (years)
 
 
 
(Dollars in thousands)
 
Unvested stock options and stock appreciation rights
  $
3,255
     
1.3
    $
7,216
     
2.1
    $
6,777
     
2.1
 
Unvested restricted stock grants
   
11,146
     
2.2
     
5,850
     
2.1
     
4,090
     
2.1
 
Unvested performance share awards
   
13,409
     
2.0
     
5,117
     
2.0
     
3,267
     
1.7
 
Total unrecognized compensation expense
  $
27,810
     
2.0
    $
18,183
     
2.0
    $
14,134
     
2.0
 
 
 
b. Employee Benefit Plan
 
We have a defined contribution plan pursuant to Section
401(k)
of the Internal Revenue Code. Each employee
may
elect to make before-tax contributions up to the current tax limits. The Company matches employee contributions up to
$7,000
per employee per year. The Company provides this plan to help its employees save a portion of their cash compensation for retirement in a tax efficient environment. Our contributions to the plan for the years ended
December
31,
2016,
2015
and
2014,
were
$10.2
million,
$4.7
million and
$3.6
million, respectively.